DHR:NYE-Danaher Corporation (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 259.26

Change

+7.65 (+3.04)%

Market Cap

USD 54.15B

Volume

2.60M

Analyst Target

USD 220.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Danaher Corp designs, manufactures & markets professional, medical, industrial & commercial products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-14 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
TMO Thermo Fisher Scientific Inc

N/A

USD 216.81B
IQV IQVIA Holdings Inc

N/A

USD 41.83B
A Agilent Technologies Inc

N/A

USD 38.80B
MTD Mettler-Toledo International I..

N/A

USD 29.99B
WAT Waters Corporation

N/A

USD 18.32B
LH Laboratory Corporation of Amer..

N/A

USD 16.43B
DGX Quest Diagnostics Incorporated

N/A

USD 15.68B
RVTY Revvity Inc.

N/A

USD 13.98B
CRL Charles River Laboratories

N/A

USD 10.74B
QGEN Qiagen NV

N/A

USD 9.70B

ETFs Containing DHR

PIO Invesco Global Water ETF 8.44 % 0.75 %

N/A

USD 0.28B
PHO Invesco Water Resources E.. 8.26 % 0.60 %

N/A

USD 2.13B
SYNB Putnam Biorevolution ETF 7.28 % 0.00 %

N/A

USD 5.43M
AILG 6.99 % 0.00 %

N/A

N/A
DXSF:XETRA Xtrackers - Stoxx Europe .. 5.91 % 0.00 %

N/A

USD 0.08B
LIFE-U:CA Evolve Global Healthcare .. 5.22 % 0.00 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 5.15 % 0.75 %

N/A

CAD 0.09B
FHI-B:CA CI Health Care Giants Cov.. 5.15 % 0.00 %

N/A

CAD 0.05B
LIFE-B:CA Evolve Global Healthcare .. 5.08 % 0.00 %

N/A

CAD 0.01B
HHL-U:CA Harvest Healthcare Leader.. 4.95 % 0.00 %

N/A

N/A
HHL-B:CA Harvest Healthcare Leader.. 4.95 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.68 % 0.00 %

N/A

USD 3.46M
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.60 % 0.00 %

N/A

USD 3.46M
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.56 % 0.00 %

N/A

USD 0.15B
YALL God Bless America ETF 4.47 % 0.00 %

N/A

USD 0.07B
BCHP 4.45 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 4.34 % 0.00 %

N/A

USD 1.13B
MIVG:CA Mackenzie Ivy Global Equi.. 4.32 % 0.89 %

N/A

CAD 0.01B
BCUS Exchange Listed Funds Tru.. 3.96 % 0.00 %

N/A

USD 0.03B
SANE 3.95 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 3.80 % 0.00 %

N/A

USD 0.03B
XSHC:LSE Xtrackers MSCI USA Health.. 3.33 % 0.00 %

N/A

USD 0.79B
XUHC:LSE Xtrackers MSCI USA Health.. 3.33 % 0.00 %

N/A

USD 0.79B
XUHC:F Xtrackers (IE) Public Lim.. 3.23 % 0.00 %

N/A

USD 0.85B
XUHC:XETRA Xtrackers MSCI USA Health.. 3.23 % 0.00 %

N/A

USD 0.85B
XUHC:SW Xtrackers MSCI USA Health.. 3.23 % 0.00 %

N/A

USD 0.79B
IUHC:LSE iShares S&P 500 USD Healt.. 3.21 % 0.00 %

N/A

USD 2.24B
QDVG:F iShares S&P 500 Health Ca.. 3.17 % 0.00 %

N/A

USD 2.09B
QDVG:XETRA iShares S&P 500 Health Ca.. 3.17 % 0.00 %

N/A

USD 2.05B
IYH iShares U.S. Healthcare E.. 3.12 % 0.43 %

N/A

USD 3.35B
IUHC:SW iShares S&P 500 Health Ca.. 3.12 % 0.00 %

N/A

USD 2.24B
ZPDH:F SPDR S&P U.S. Health Care.. 3.12 % 0.00 %

N/A

USD 0.40B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 3.12 % 0.00 %

N/A

USD 0.40B
GXLV:LSE SPDR® S&P® U.S. Health .. 3.12 % 0.00 %

N/A

USD 0.39B
SXLV:SW SPDR S&P U.S. Health Care.. 3.12 % 0.00 %

N/A

N/A
FHLC Fidelity® MSCI Health Ca.. 3.01 % 0.08 %

N/A

USD 3.03B
HIUS:PA HSBC MSCI USA Islamic ESG.. 2.77 % 0.00 %

N/A

N/A
HIUA:SW HSBC MSCI USA Islamic ESG.. 2.77 % 0.00 %

N/A

USD 0.03B
DRUP GraniteShares ETF Trust -.. 2.74 % 0.00 %

N/A

USD 0.06B
USRI:PA AMUNDI MSCI USA SRI Clima.. 2.72 % 0.00 %

N/A

USD 2.88B
WEBD:XETRA AETF-MUSCNZAP EOA ETF 2.72 % 0.00 %

N/A

N/A
UC96:LSE UBS (Irl) ETF plc - Facto.. 2.61 % 0.00 %

N/A

USD 0.31B
UPVL:LSE UBS (Irl) ETF plc - Facto.. 2.61 % 0.00 %

N/A

USD 8.50M
UBUS:F UBS (Irl) ETF Public Limi.. 2.53 % 0.00 %

N/A

USD 0.32B
UBUW:F UBS (Irl) ETF Public Limi.. 2.53 % 0.00 %

N/A

USD 0.02B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 2.53 % 0.00 %

N/A

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 2.53 % 0.00 %

N/A

USD 0.05B
UPVLE:SW UBS (Irl) ETF plc - Facto.. 2.53 % 0.00 %

N/A

USD 0.02B
UPVLD:SW UBS (Irl) ETF plc - Facto.. 2.53 % 0.00 %

N/A

USD 0.31B
UPVLH:SW UBS (Irl) ETF plc - Facto.. 2.53 % 0.00 %

N/A

USD 8.50M
CURE Direxion Daily Healthcare.. 2.52 % 1.06 %

N/A

USD 0.19B
USRI:LSE 2.50 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.25 % 0.00 %

N/A

USD 0.05B
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.25 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.25 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 2.23 % 0.00 %

N/A

CAD 0.08B
DSAE:CA Desjardins SocieTerra Ame.. 2.21 % 0.00 %

N/A

CAD 1.19M
SUAP:LSE iShares MSCI USA SRI UCIT.. 2.16 % 0.00 %

N/A

USD 0.05B
3SUR:F iShares IV Public Limited.. 2.14 % 0.00 %

N/A

N/A
SUAS:SW iShares MSCI USA SRI UCIT.. 2.10 % 0.00 %

N/A

USD 5.83B
BMED BlackRock Future Health E.. 1.84 % 0.00 %

N/A

USD 4.21M
XMLH:XETRA L&G Healthcare Breakthrou.. 1.80 % 0.00 %

N/A

USD 0.07B
XMLH:F Legal & General Ucits Etf.. 1.80 % 0.00 %

N/A

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 1.80 % 0.00 %

N/A

USD 0.07B
QDVR:F iShares MSCI USA SRI UCIT.. 1.58 % 0.00 %

N/A

USD 7.94B
3SUR:XETRA iShares MSCI USA SRI UCIT.. 1.58 % 0.00 %

N/A

USD 0.40B
QDVR:XETRA iShares MSCI USA SRI UCIT.. 1.58 % 0.00 %

N/A

USD 7.22B
36B6:XETRA iShares MSCI USA SRI UCIT.. 1.58 % 0.00 %

N/A

USD 6.76B
XAMB:F Amundi Index Solutions - .. 1.53 % 0.00 %

N/A

N/A
HYLG Global X Funds - Global X.. 1.44 % 0.00 %

N/A

USD 2.85M
WSRI:PA Amundi MSCI World SRI Cli.. 1.39 % 0.00 %

N/A

USD 3.84B
XAMB:XETRA Amundi MSCI World SRI Cli.. 1.39 % 0.00 %

N/A

USD 4.92B
MWSH:XETRA Amundi MSCI World SRI Cli.. 1.39 % 0.00 %

N/A

USD 4.92B
WGES:XETRA Amundi MSCI World SRI Cli.. 1.39 % 0.00 %

N/A

USD 4.30B
WESE:PA Lyxor MSCI World ESG Lead.. 1.39 % 0.00 %

N/A

N/A
LESW:LSE 1.38 % 0.00 %

N/A

N/A
WSRI:LSE 1.30 % 0.00 %

N/A

N/A
WELA:XETRA Amundi MSCI ACWI SRI PAB .. 1.22 % 0.00 %

N/A

USD 0.07B
WELB:XETRA Amundi MSCI ACWI SRI PAB .. 1.08 % 0.00 %

N/A

USD 0.07B
USXF iShares® ESG Advanced MS.. 1.00 % 0.00 %

N/A

USD 1.05B
EMWE:PA BNP Paribas Easy MSCI Wor.. 0.88 % 0.00 %

N/A

USD 0.73B
EWRD:PA BNP Paribas Easy MSCI Wor.. 0.88 % 0.00 %

N/A

USD 0.06B
EMWE:XETRA BNP Paribas Easy MSCI Wor.. 0.88 % 0.00 %

N/A

USD 0.55B
RAVI FlexShares Ready Access V.. 0.86 % 0.25 %

N/A

USD 1.14B
CWW.A:CA 0.00 % 1.49 %

N/A

N/A
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

N/A

USD 3.98B
JHMH 0.00 % 0.46 %

N/A

N/A
JMIN 0.00 % 0.12 %

N/A

N/A
EVSTC 0.00 % 0.00 %

N/A

N/A
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

N/A

CAD 0.05B
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

N/A

CAD 0.05B
LS:CA Middlefield Healthcare & .. 0.00 % 2.21 %

N/A

CAD 0.16B
HWF:CA 0.00 % 0.00 %

N/A

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

N/A

USD 0.09B
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

N/A

USD 17.71B
XLV Health Care Select Sector.. 0.00 % 0.13 %

N/A

USD 39.31B
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

N/A

CAD 0.33B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

N/A

CAD 0.01B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

USD 1.69B
SUUS:LSE iShares Sustainable MSCI .. 0.00 % 0.00 %

N/A

USD 5.90B
SUWS:LSE iShares MSCI World SRI UC.. 0.00 % 0.00 %

N/A

USD 1.63B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

USD 0.39B
SUAS:LSE iShares Sustainable MSCI .. 0.00 % 0.00 %

N/A

USD 5.95B
GNAR:F 0.00 % 0.00 %

N/A

N/A
EWRD:XETRA 0.00 % 0.00 %

N/A

N/A
GNAR:XETRA 0.00 % 0.00 %

N/A

N/A
VMOM:XETRA 0.00 % 0.00 %

N/A

N/A
XOUT GraniteShares XOUT U.S. L.. 0.00 % 0.00 %

N/A

USD 0.06B
VNSE Natixis ETF Trust II - Na.. 0.00 % 0.00 %

N/A

USD 0.03B
2B7K:F iShares MSCI World SRI UC.. 0.00 % 0.00 %

N/A

N/A
36B6:F iShares MSCI USA SRI UCIT.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.07% 93% A 80% B-
Dividend Return 0.12% 29% F 4% F
Total Return 12.19% 93% A 78% C+
Trailing 12 Months  
Capital Gain 15.23% 67% D+ 60% D-
Dividend Return 0.47% 33% F 4% F
Total Return 15.70% 67% D+ 54% F
Trailing 5 Years  
Capital Gain 96.01% 73% C 86% B+
Dividend Return 3.32% 40% F 10% F
Total Return 99.33% 73% C 84% B
Average Annual (5 Year Horizon)  
Capital Gain 16.20% 67% D+ 80% B-
Dividend Return 16.60% 67% D+ 79% B-
Total Return 0.40% 67% D+ 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 29.41% 58% F 38% F
Risk Adjusted Return 56.44% 75% C 79% B-
Market Capitalization 54.15B 92% A 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.10 25% 13%
Price/Book Ratio 3.32 62% 26%
Price / Cash Flow Ratio 26.00 38% 11%
Price/Free Cash Flow Ratio 25.53 8% 9%
Management Effectiveness  
Return on Equity 7.76% 38% 48%
Return on Invested Capital 6.92% 43% 53%
Return on Assets 3.86% 38% 63%
Debt to Equity Ratio 31.24% 69% 73%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.